Drug Profile
Research programme: cancer vaccine - Recopharma
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Recopharma
- Class Cancer vaccines
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Sweden
- 13 Jul 2010 Preclinical trials in Cancer in Sweden (unspecified route)